Hilleman Laboratories, the Singapore-based Merck (MRK) and Wellcome joint venture, is manufacturing an experimental Bundibugyo-strain Ebola vaccine for clinical trials as Congo’s outbreak surpasses 1,000 deaths and no approved shot exists for that species.
For Merck shareholders,...